Abeona Therapeutics Cash Flow Statement (2010-2026) | ABEO

Cash Flow Statement Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-15.21M-15.54M-46.67M-20.79M-8.18M-9.54M-13.11M-12.14M-10.66M-11.44M-13.32M-15.28M7.41M-30.27M-9.29M-12.03M124.34M-5.16M-20.46M-17.07M
Depreciation and Depletion (Quarter)
0.80M0.70M
Share-based Compensation (Quarter)
2.43M2.54M2.00M0.86M0.72M0.63M0.83M0.77M0.93M1.56M1.51M1.55M1.32M1.80M1.96M2.70M2.83M2.69M2.56M2.96M
Gains from Sales and Divestitures (Quarter)
0.03M0.27M0.04M0.82M0.97M1.01M0.07M0.50M1.40M1.46M0.91M
Gains from Investment Securities (Quarter)
0.00M0.00M-0.02M0.20M-4.20M-3.05M5.89M0.01M8.63M1.10M-7.51M0.18M0.18M0.18M0.01M0.97M5.39M-2.76M-6.58M0.34M
Asset Writedowns and Impairment (Quarter)
3.25M-1.69M0.24M0.71M
Non-cash Items (Quarter)
0.00M0.01M0.15M0.16M0.01M0.00M0.17M0.17M0.01M0.00M
Cash from Operations (Quarter)
-11.49M-10.33M-30.26M-13.69M-9.01M-6.79M-13.99M-11.74M-10.28M-5.75M-9.23M-14.54M-12.68M-12.23M-16.56M-18.40M-18.78M-21.19M-17.95M-19.80M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.53M0.01M1.47M0.30M0.60M-0.69M0.17M0.12M-0.04M0.61M0.23M0.06M0.01M-0.12M0.96M-0.46M0.96M0.28M-1.67M0.18M
Depreciation & Amortization (CF) (Quarter)
0.02M0.02M0.81M0.81M0.77M0.78M0.73M0.66M0.61M0.52M0.49M0.49M0.49M0.49M0.54M0.53M0.54M0.61M0.86M0.69M
Change in Working Capital
Change in Receivables (Quarter)
-3.00M4.83M-4.83M0.07M1.96M-0.02M0.02M-0.25M-0.55M-0.03M0.04M-0.04M0.01M-0.01M-1.05M0.05M
Change in Inventory (Quarter)
2.16M0.64M0.56M
Change in Account Payables (Quarter)
1.50M0.67M-20.00M-0.30M7.00M
Change in Accured Expenses (Quarter)
-1.95M0.52M5.28M-4.39M0.70M-1.44M4.83M0.00M-0.01M-0.20M-1.69M1.57M-0.08M1.71M-2.38M3.68M1.00M-2.39M-7.32M
Change in Taxes (Quarter)
0.11M15.40M-15.17M-0.21M-0.13M
Investing Activities
Capital Expenditures (Quarter)
0.06M0.40M3.25M0.10M0.00M0.03M0.22M0.03M0.04M0.04M0.72M0.71M0.40M0.61M1.40M2.90M2.52M1.15M0.94M
Sales of Property, Plant and Equipment (Quarter)
0.10M0.14M0.01M0.02M
Change in Intangibles (Quarter)
Change in Acquisitions & Divestments (Quarter)
21.98M27.16M16.25M8.66M24.07M10.97M8.94M10.39M11.26M15.36M14.97M22.25M17.11M50.87M29.96M54.26M26.28M71.83M14.90M24.90M
Cash from Investing Activities (Quarter)
21.92M26.76M8.00M1.07M-1.40M1.65M-25.29M2.21M5.21M-18.74M11.53M-7.82M-44.13M-6.17M18.88M4.21M155.89M-64.63M9.55M4.96M
Financing Activities
Other financing activities (Quarter)
0.96M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
20.00M
Long-Term Debt Repayments (Quarter)
2.22M
Short-Term Debt issuances (Quarter)
Short-Term Debt repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
7.00M0.03M0.35M28.41M16.36M-8.57M6.42M3.54M60.19M-54.68M6.80M10.50M3.60M
Dividend Payments
Dividends Paid - Preferred (Quarter)
Misc.
Cash from Financing Activities (Quarter)
2.48M0.17M16.33M4.19M42.77M-0.00M6.62M22.98M7.47M25.44M73.68M-0.30M5.31M6.77M10.49M5.16M3.61M-2.22M
Change in Cash (Quarter)
12.91M16.60M-5.93M-12.61M-14.19M-0.95M3.48M-9.54M1.54M-1.51M9.76M3.08M16.87M-18.70M7.63M-7.42M147.60M-80.65M-4.79M-17.06M
Free Cash Flow (Quarter)
-11.55M-10.74M-33.51M-13.79M-9.01M-6.79M-14.02M-11.96M-10.32M-5.79M-9.27M-15.26M-13.39M-12.64M-17.16M-19.80M-21.68M-23.71M-19.11M-20.74M
Net Cash Flow (Quarter)
12.91M16.60M-5.93M-12.61M-10.41M-0.95M3.48M-9.54M1.54M-1.51M9.76M3.08M16.87M-18.70M7.63M-7.42M147.60M-80.65M-4.79M-17.06M